We've been clear. The commitment on intellectual property has not been reached for many years now. I think that's a matter for IMC to address with the government.
We have particularly raised this point when there have been discussions in international trade agreements, where countries like the United States, or the European Commission, have pressured Canada to increase intellectual property protection. We have pointed out that, in the past, when Canada made agreements around certain levels of research and development in return for greater intellectual property protection, it didn't work out. We continue to say that in trade agreements, intellectual property protection in Canada needs to be addressed from a Canadian perspective. You need to look at the amount of research and development, the jobs and the health care savings available.
Every year that a patent or intellectual property is extended means that the generics, which are priced in some cases at a 90% discount, will not be available. That's a very high price to pay in the health care system.